 |
Investor Relations |
|
| |
|
|
|
|
|
| Notifications |
|
| |
|
| 2008-11-7 : Director Purchase of Shares-Correction
CMSH announces that on 31 October 2008 Mr. Chen Hongbing, the Executive Vice President and a director of the Company ¡ more
2008-10-30 : Result of EGM
CMSH is pleased to announce that at the Company Extraordinary Meeting held this morning ¡ more
2008-10-28 : Accredited as one of ¡°Asia¡®s Best Under A Billion¡° by Forbes
CMSH is pleased to announce that the Company was recently accredited to the Forbes list of ¡ more
2008-10-16 : Exclusive Agency and Distribution Agreement for Salofalk
CMSH is pleased to announce that the Company has signed an agreement with Falk Pharma GmbH, to gain the exclusive ¡ more
2008-10-13 : Director Purchase of Shares
CMSH announces that on 10 October 2008 Mr Chen Hongbing, the Executive Vice President and a director of ¡ more
2008-9-29 : Notice of Extraordinary General Meeting
Notice is hereby given that the Extraordinary General Meeting of shareholders of the Company will be held at ¡ more
2008-9-29 : 2008 Interim Results Announcement
CMSH is pleased to announce its interim results for the six months ended 30 June 2008 ¡ more
2008-9-19 : Notice of Interim Results
CMSH is pleased to announce that it will be releasing the Interim Results for the six months ¡ more
2008-7-31 : China Medical System has been approved to commence the Phase 2 clinical trial for a novel cancer treatment
CMSH is pleased to announce that it has received approval from the SFDA to commence the Phase II clinical trial for CMS024-02 ¡ more
2008-7-25 : Trading Update
CMSH is pleased to announce a trading update for the first six months ending 30 June 2008. ¡ more
2008-7-18 : Director Purchase of Shares
CMSH announces that on 16 July 2008 Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased 20,000 ordinary shares ¡ more
2008-7-17 : Exclusive Agency and Distribution Agreement for Augentropfen Stulln Mono
CMSH is pleased to announce that the company has reached an agreement with its marketing partner, Ophol Ltd., to gain full control of distributing Augentropfen Stulln Mono ("Stulln") ¡ more
2008-7-16 : Director Purchase of Shares
CMSH announces that on 14 July 2008 Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased 2,500 ordinary shares ¡ more
2008-7-16 : Change of Nominated Adviser and Broker
CMSH is pleased to announce the appointment of Seymour Pierce Limited as Nominated Adviser and Broker to the Company, with immediate ¡ more
2008-7-15 : Director Purchase of Shares
CMSH announces that Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased a total of 30,000 ordinary shares of US$0.1 each of the Company ¡ more
2008-7-9 : Director Purchase of Shares
CMSH announces that Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased a total ¡ more
2008-7-2 : Director Purchase of Shares
CMSH announces that on 27 June 2008 Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased ¡ more
2008-6-26 : Director Purchase of Shares
CMSH announces that on 23 and 24 June 2008 Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased ¡ more
2008-6-24 : Director Purchase of Shares
CMSH announces that on 20 June 2008 Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased ¡ more
2008-6-23 : Director Purchase of Shares
CMSH announces that on 18 June 2008 Mr. Chen Hongbing, the Executive Vice President and a director of the Company, purchased ¡ more
2008-6-20 : Director Purchase of Shares
CMSH announces that on 17 June 2008 Mr. Chen Hongbing, the Executive Vice President and a director of ¡ more
2008-5-23 : Director Purchase of Shares
CMSH announces that on 19 May 2008 Mr. Chen Hongbing, the Executive Vice President ¡ more
2008-5-19 : Director Purchase of Shares
CMSH announces that on 15 May 2008 Ms. Hou Xiaoxuan, the Executive Director of the Company, purchased ¡ more
2008-5-14 : Sichuan Earthquake Update
CMSH would like to issue a statement regarding the earthquake in the Sichuan province of PRC.
¡ more
2008-4-30 : Result of Annual General Meeting
CMSH is pleased to announce that at the Company Annual General Meeting (AGM) held this morning, all the resolutions proposed were duly passed ¡ more
2008-4-28 : Renewal of Import Drug License of Deanxit
CMS is pleased to announce that the Chinese State Food and Drug Administration (¡°the SFDA¡±) has approved the renewal of the Import Drug License (¡°the license¡±) of Deanxit. ¡ more
2008-4-22 : Extension of Exclusive Agency and Distribution Agreement for Deanxit
CMS is pleased to announce that it has today signed an addendum extending the exclusive agency agreement entered into in 2002 ¡ more
2008-4-7 : Annual Report and Accounts 2007 & Notice of Annual General Meeting
CMSH is pleased to announce that its Annual Reports and Accounts for the year ended 31 December 2007 ¡ more
2008-4-3 : Maiden Final Results For the year ended 31 December 2007
CMSH is pleased to announce its maiden final results for the year ended 31 December 2007 ¡ more
2008-3-26 : Exclusive Agency and Distribution Agreement for Cystistat
CMSH is pleased to announce that it has signed an exclusive agency and distribution agreement with Bioniche Teoranta to distribute ¡ more
2008-3-18 : Notification of Preliminary Results For the year ended 31 December 2008
CMSH today announces that it will be releasing its preliminary results for the twelve months ended 31 December 2007 ¡ more
2008-3-10 : Exclusive Agency and Distribution Agreement for Nesiritide
CMSH is pleased to announce that it has yesterday signed an exclusive agency and distribution agreement with Tibet Rhodiola Pharmaceutical Holding Company ¡ more
2008-1-17 : CMS024 for the treatment of liver cancer receives SFDA Assessment Notice
CMSH today announces that it has received an Assessment Notice from the State Food and Drug Administration of China (SFDA) ¡ more
2008-1-4 : Trading Update
CMSH is pleased to announce an update on the company trading for the year ended 31 December 2007 ¡ more
|
|
